• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE INNOVA¿; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE INNOVA¿; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number H74939180072070
Device Problems Detachment Of Device Component (1104); Activation, Positioning or Separation Problem (2906); Device Dislodged or Dislocated (2923)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/11/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that deployment issues, stent dislodgement and tip detachment occurred.The target lesion was located in the superficial femoral artery.Following the insertion of a 0.018 non-bsc guide wire and 6f non-bsc guide sheath, a 7x200x75 innova¿ stent was advanced to treat the lesion.Deployment was started and when around 5cm of the stent was deployed, the thumbwheel could no longer move.The physician then attempted to release the stent with the pull grip, but the grip was also locked.When the physician attempted to remove the delivery system, the stent dislocated to the proximal femoral artery.Subsequently, the physician removed the sheath with the delivery system, which lead to an elongation of the stent over the aortic bifurcation and loss of the tip of the delivery system.With kissing stents, the physician covered the detached tip and the biggest part of the stent.One part of the stent is still not covered and was removed through surgery.No patient complications were reported and the patient's status was stable.
 
Manufacturer Narrative
Device evaluated by manufacturer: returned product consisted of portion of the innova stent delivery system with a.018¿ guidewire in the lumen.The guidewire was protruding 27.5cm from the distal end of the shaft and 60cm from the end of the handle.There was blood on the handle and in the shaft.The tip and inner liner (shaft) were detached/separated and not returned.The shaft was kinked at the nose cone.The x-ray showed that the guidewire was deformed within the handle rack slot.Upon opening the handle, the proximal inner (shaft) was verified to be damaged but within rack slot.The damage was noted to be adjacent to the rack o-ring.The damaged proximal inner would not pass through o-ring, essentially locking the system up with the 0.018¿ guidewire.The damage to the proximal inner is consistent with using excessive force.The stent was not received for analysis.Inspection of the remainder of the device, apart from the observed damage, revealed no other damage or irregularities.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is operational context as device performance was limited due to anatomical/ procedural factors.(b)(4).
 
Event Description
It was reported that deployment issues, stent dislodgement and tip detachment occurred.The target lesion was located in the superficial femoral artery.Following the insertion of a 0.018 non-bsc guide wire and 6f non-bsc guide sheath, a 7x200x75 innova stent was advanced to treat the lesion.Deployment was started and when around 5cm of the stent was deployed, the thumbwheel could no longer move.The physician then attempted to release the stent with the pull grip, but the grip was also locked.When the physician attempted to remove the delivery system, the stent dislocated to the proximal femoral artery.Subsequently, the physician removed the sheath with the delivery system, which lead to an elongation of the stent over the aortic bifurcation and loss of the tip of the delivery system.With kissing stents, the physician covered the detached tip and the biggest part of the stent.One part of the stent is still not covered and was removed through surgery.No patient complications were reported and the patient's status was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA¿
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5490049
MDR Text Key40016349
Report Number2134265-2016-01468
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/11/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2018
Device Model NumberH74939180072070
Device Catalogue Number39180-07207
Device Lot Number18751463
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/18/2016
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/11/2016
Initial Date FDA Received03/09/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/07/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/04/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
-
-